mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |